Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ROCK1 | Q13464 | 2/20 | 0.39 |
| ▸ | DHODH | Q02127 | 1/20 | 0.39 |
| ▸ | CCKBR | P32239 | 4/20 | 0.38 |
| ▸ | CCKAR | P32238 | 2/20 | 0.38 |
| ▸ | GRIK1 | P39086 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | PTGFR | P43088 | 1/20 | 0.35 |
| ▸ | LCK | P06239 | 2/20 | 0.34 |
| ▸ | DGAT1 | O75907 | 1/20 | 0.34 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.34 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.34 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.34 |
| ▸ | DHFR | P00374 | 1/20 | 0.34 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.34 |
| ▸ | GRM4 | Q14833 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6708878 | 0.91 | ROCK1 (0.40) | ROCK1DHODHCCKBRGRIK1KMT2A | |
| SCHEMBL6713081 | 0.91 | ROCK1 (0.43) | ROCK1DHODHCCKBRCCKARGRIK1 | |
| SCHEMBL6710341 | 0.90 | ROCK1 (0.38) | ROCK1CCKBRGRIK1KMT2APTGFR | |
| SCHEMBL6709219 | 0.88 | CCKAR (0.38) | ROCK1DHODHCCKBRCCKARLMNA | |
| SCHEMBL6710127 | 0.86 | ROCK1 (0.47) | ROCK1CCKBRCCKARGRIK1KMT2A | |
| SCHEMBL6708769 | 0.85 | GRIK1 (0.39) | ROCK1DHODHCCKBRCCKARGRIK1 | |
| SCHEMBL6710487 | 0.84 | FTO (0.42) | ROCK1GRIK1KMT2ALMNAHDAC6 | |
| SCHEMBL6711596 | 0.84 | HIF1A (0.39) | ROCK1CCKBRCCKARKMT2ALMNA | |
| SCHEMBL6714243 | 0.83 | LCK (0.37) | ROCK1GRIK1KMT2ALMNALCK | |
| SCHEMBL6714295 | 0.83 | GRIK1 (0.41) | ROCK1GRIK1KMT2ARXFP1GRM4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040142981-A1 | Antibacterial benzoic acid derivatives | PHARMACIA & UPJOHN COMPANY | 2004-07-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040142981-A1 | Antibacterial benzoic acid derivatives | GABRD, PHB1, GABBR1 | ROCK1 4830/4885DHODH 107/4885CCKBR 3495/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.